- Home
- Publications
- Publication Search
- Publication Details
Title
Dopamine and Huntington’s disease
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 15, Issue 4, Pages 445-458
Publisher
Informa UK Limited
Online
2015-03-16
DOI
10.1586/14737175.2015.1025383
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mutant huntingtin is present in neuronal grafts in huntington disease patients
- (2014) Francesca Cicchetti et al. ANNALS OF NEUROLOGY
- Huntington disease: natural history, biomarkers and prospects for therapeutics
- (2014) Christopher A. Ross et al. Nature Reviews Neurology
- Role of Dopamine D2 Receptors in Human Reinforcement Learning
- (2014) Christoph Eisenegger et al. NEUROPSYCHOPHARMACOLOGY
- Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records
- (2013) Stephen JW Evans et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease
- (2013) MOVEMENT DISORDERS
- Multisource ascertainment of Huntington disease in Canada: Prevalence and population at risk
- (2013) Emily R. Fisher et al. MOVEMENT DISORDERS
- Clinical Neurogenetics
- (2013) Yvette M. Bordelon NEUROLOGIC CLINICS
- Prefrontal dopamine signaling and cognitive symptoms of Parkinson’s disease
- (2013) Nandakumar S. Narayanan et al. REVIEWS IN THE NEUROSCIENCES
- Motor function and dopamine release measurements in transgenic Huntington's disease model rats
- (2012) Andrea N. Ortiz et al. BRAIN RESEARCH
- Tetrabenazine for the Treatment of Hyperkinetic Movement Disorders: A Review of the Literature
- (2012) Jack J. Chen et al. CLINICAL THERAPEUTICS
- Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice
- (2012) M. A. Pouladi et al. HUMAN MOLECULAR GENETICS
- The dopamine stabilizers ACR16 and (−)-OSU6162 display nanomolar affinities at the σ-1 receptor
- (2012) K Sahlholm et al. MOLECULAR PSYCHIATRY
- Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial
- (2011) Justo Garcia de Yebenes et al. LANCET NEUROLOGY
- Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data
- (2011) Sarah J Tabrizi et al. LANCET NEUROLOGY
- Huntington's Disease: Can Mice Lead the Way to Treatment?
- (2011) Zachary R. Crook et al. NEURON
- Impaired dopamine release and uptake in R6/1 Huntington's disease model mice
- (2011) Andrea N. Ortiz et al. NEUROSCIENCE LETTERS
- Serotonin and dopamine striatal innervation in Parkinson’s disease and Huntington’s chorea
- (2011) Catherine Bédard et al. PARKINSONISM & RELATED DISORDERS
- The Physiology, Signaling, and Pharmacology of Dopamine Receptors
- (2011) J.-M. Beaulieu et al. PHARMACOLOGICAL REVIEWS
- Efficacy and Safety of the Dopaminergic Stabilizer Pridopidine (ACR16) in Patients With Huntington's Disease
- (2010) Anders Lundin et al. CLINICAL NEUROPHARMACOLOGY
- Bromocriptine, an ergot alkaloid, inhibits excitatory amino acid release mediated by glutamate transporter reversal
- (2010) Yasufumi Shirasaki et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- In vivo pharmacology of the dopaminergic stabilizer pridopidine
- (2010) Henrik Ponten et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Extrastriatal dopamine D2receptor binding in Huntington's disease
- (2010) Mouna Esmaeilzadeh et al. HUMAN BRAIN MAPPING
- Synthesis and Evaluation of a Set of 4-Phenylpiperidines and 4-Phenylpiperazines as D2Receptor Ligands and the Discovery of the Dopaminergic Stabilizer 4-[3-(Methylsulfonyl)phenyl]-1-propylpiperidine (Huntexil, Pridopidine, ACR16)
- (2010) Fredrik Pettersson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease
- (2010) Marta Martinez-Vicente et al. NATURE NEUROSCIENCE
- Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease
- (2010) Samuel Frank Neuropsychiatric Disease and Treatment
- Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators
- (2009) Samuel Frank BMC Neurology
- Emerging drug therapies in Huntington's disease
- (2009) Sarah L Mason et al. EXPERT OPINION ON EMERGING DRUGS
- Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers
- (2009) Nicola Pavese et al. NEUROBIOLOGY OF DISEASE
- The Neural Circuitry of Executive Functions in Healthy Subjects and Parkinson's Disease
- (2009) Sandra E Leh et al. NEUROPSYCHOPHARMACOLOGY
- Hypothalamic involvement in Huntington's disease: an in vivo PET study
- (2008) M. Politis et al. BRAIN
- A Study of Chorea After Tetrabenazine Withdrawal in Patients With Huntington Disease
- (2008) Samuel Frank et al. CLINICAL NEUROPHARMACOLOGY
- The Long-term Effect of Tetrabenazine in the Management of Huntington Disease
- (2008) Alfonso Fasano et al. CLINICAL NEUROPHARMACOLOGY
- Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington’s disease
- (2008) J.C.H. van Oostrom et al. EUROPEAN JOURNAL OF NEUROLOGY
- Mechanisms of neurodegeneration in Huntington’s disease
- (2008) Joana M. Gil et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II
- (2008) Alexandra Benchoua et al. HUMAN MOLECULAR GENETICS
- A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease
- (2008) Maria Björkqvist et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Full-Length Human Mutant Huntingtin with a Stable Polyglutamine Repeat Can Elicit Progressive and Selective Neuropathogenesis in BACHD Mice
- (2008) M. Gray et al. JOURNAL OF NEUROSCIENCE
- How dopamine dysregulation leads to psychotic symptoms? Abnormal mesolimbic and mesostriatal prediction error signalling in psychosis
- (2008) G K Murray et al. MOLECULAR PSYCHIATRY
- A Europe-wide assessment of current medication choices in Huntington's disease
- (2008) Josef Priller et al. MOVEMENT DISORDERS
- Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine
- (2008) Livia Brusa et al. MOVEMENT DISORDERS
- Atrophy and degeneration in sciatic nerve of presymptomatic mice carrying the Huntington's disease mutation
- (2007) Anna Wade et al. BRAIN RESEARCH
- Detection of Huntington's disease decades before diagnosis: the Predict-HD study
- (2007) J S Paulsen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo
- (2007) Delphine Charvin et al. NEUROBIOLOGY OF DISEASE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search